GENUS

Company Snapshot

Founded: 1994
Entity Type: Public
Employees: 3,581
Region: North America
Revenue: $842.2 Millions
Revenue Year: 2024
Headquarter: Hampshire, U.K.
Key Geographics: North America, Latin America, U.K., Rest of Europe, Middle East, Russia, Africa, Asia
Corporate Address: Matrix House, Basing View, Basingstoke Hampshire, RG21 4DZ U.K. Tel. +44-0-1256-347100 www.genusplc.com

Company Overview

Genus PLC is an animal genetics company that develops better pigs and cows for farmers. The company uses gene editing to add desirable traits, including high-quality meat and milk. Genus is a global leader in animal genetics improvement.

In May 2016, Genus formed a strategic alliance with Caribou Biosciences, giving Genus access to CRISPR-Cas9 gene-editing technology.

In 2018, Genus performed in-house genome editing on beef and dairy embryos that targeted the CD18 gene. This work provided proof of concept that a single change to this gene could improve resistance to bovine respiratory disease.

Genus edits the CD163 gene in elite PIC genetics to produce pigs that resist PRRSv infection through its subsidiary RenOVAte Biosciences.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
Operating Income: ***

This information is available for BCC Research members only.

GENUS In Reports

Synthetic Biology: Global Markets

BCC Research Market Report for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate of 28.4%

Agricultural Biotechnology: Emerging Technologies and Global Markets

The global market for agricultural biotechnology products should grow from $50.5 billion in 2019 to $72.2 billion by 2024 with a compound annual growth rate (CAGR) of 7.4% for the period of 2019-2024.

Synthetic Biology: Global Markets

The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.

Company's Business Segments

  • Genus PIC : Global Porcine Sales Business
  • Genus ABS : Global Bovine Sales Business
  • Central : Global spend on Research and Development

Applications/End User Industries

  • Agriculture
  • Dairy Industry
  • Biotechnology
  • Livestock Farming
AI Sentiment